Use of GLUT-4 null mice to study skeletal muscle glucose uptake

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 4, 2005, Pages 308-313

  Charron, Maureen J ^a   Gorovits, Naira ^a   Laidlaw, J Skye ^a   Ranalletta, Mollie ^a   Katz, Ellen B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Glucose transporter; Glucose uptake; GLUT 4; Insulin action; Skeletal muscle

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 4; MUSCLE PROTEIN; MYOSIN LIGHT CHAIN;

DISORDERS OF CARBOHYDRATE METABOLISM; FAST MUSCLE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID METABOLISM; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; GENE EXPRESSION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; LIPID METABOLISM; LIPIDS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE FIBERS, FAST-TWITCH; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSIN LIGHT CHAINS;

EID: 17844381000     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04189.x     Document Type: Review

References (45)

1. Lund-Andersen H. Transport of glucose from blood to brain. Physiol. Rev. 1979; 59: 305-52.
2. Pardridge WM. Brain metabolism: A perspective from the blood-brain barrier. Physiol. Rev. 1983; 63: 1481-535.
3. Mauvais-Jarvis F, Kahn CR. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: What can we learn from transgenic and knockout mice? Diabetes Metab. 2000; 26: 433-48.
4. Nakae J, Kido Y, Accili D. Tissue-specific insulin resistance in type 2 diabetes: Lessons from gene-targeted mice. Ann. Med. 2001; 33: 22-7.
5. Kahn CR, Bruning JC, Michael MD, Kulkarni RN. Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus. J. Pedlatr. Endocrinol. Metab. 2000; 13 (Suppl. 6): 1377-84.
6. Katz EB, Burcelin R, Tsao TS, Stenbit AE, Charron MJ. The metabolic consequences of altered glucose transporter expression in transgenic mice. J. Mol. Med. 1996; 74: 639-52.
7. Rajewsky K, Gu H, Kuhn R et al. Conditional gene targeting. J. Clin. Invest. 1996; 98: 600-3.
8. Kahn BB. Facilitative glucose transporters: Regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 1992; 89: 1367-74.
9. Mueckler M. Facilitative glucose transporters. Eur. J. Biochem. 1994; 219: 713-25.
10. Pessin JE, Thurmond DC, Elmendorf JS, Coker KJ, Okada S. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location! J. Biol. Chem. 1999; 274: 2593-6.
11. Simpson F, Whitehead JP, James DE. GLUT4 - at the cross roads between membrane trafficking and signal transduction. Traffic 2001; 2: 2-11.
12. Shepherd PR, Kahn BB. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 1999; 341: 248-57.
13. Klip A, Marette A. Acute and chronic signals controlling glucose transport in skeletal muscle. J. Cell. Biochem. 1992; 48: 51-60.
14. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995; 377: 151-5.
15. Stenbit AE, Katz EB, Chatham JC et al. Preservation of glucose metabolism in hypertrophic GLUT4-null hearts. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H313-18.
16. Charron MJ, Katz EB, Olson AL. GLUT4 gene regulation and manipulation. J. Biol. Chem. 1999; 274: 3253-6.
17. Galuska D, Ryder J, Kawano Y, Charron MJ, Zierath JR. Insulin signaling and glucose transport in insulin resistant skeletal muscle. Special reference to GLUT4 transgenic and GLUT4 knockout mice. Adv. Exp. Med. Biol. 1998; 441: 73-85.
18. Abel ED, Kaulbach HC, Tian R et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 1999; 104: 1703-14.
19. Abel ED, Peroni O, Kim JK et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409: 729-33.
20. Zisman A, Peroni OD, Abel ED et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 2000; 6: 924-8.
21. Stenbit AE, Tsao TS, Li J et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 1997; 3: 1096-101.
22. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000-7.
23. Stenbit AE, Burcelin R, Katz EB et al. Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle. J. Clin. Invest. 1996; 98: 629-34.
24. Ryder JW, Kawano Y, Chibalin AV et al. In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle. Biochem. J. 1999; 342: 321-8.
25. Czech MP, Corvera S. Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 1999; 274: 1865-8.
26. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Ann. Rev. Med. 1998; 49: 235-61.
27. Rodnick KJ, Piper RC, Slot JW, James DE. Interaction of insulin and exercise on glucose transport in muscle. Diabetes Care 1992; 15: 1679-89.
28. Zierath JR, Tsao TS, Stenbit AE, Ryder JW, Galuska D, Charron MJ. Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J. Biol. Chem. 1998; 273: 20 910-15.
29. Ryder JW, Kawano Y, Galuska D et al. Postexercise glucose uptake and glycogen synthesis in skeletal muscle from GLUT4-deficient mice. FASEB J. 1999; 13: 2246-56.
30. Derave W, Hansen BF, Lund S, Kristiansen S, Richter EA. Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity. Am. J. Physiol. Endocrinol. Metab. 2000; 279: E947-55.
31. Gorselink M, Drost MR, de Brouwer KF et al. Increased muscle fatigability in GLUT-4-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2002; 282: E348-54.
32. Bottinelli R, Schiaffino S, Reggiani C. Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J. Physiol. 1991; 437: 655-72.
33. Ladriere L, Charron MJ, Malaisse WJ. Metabolism of d-glucose and its pentaacetate ester in muscles and pancreatic islets of GLUT4 null mice. Biochem. Biophys. Res. Commun. 1999; 264: 855-9.
34. Malaisse WJ, Jijakli H, Kadiata MM, Sener A, Kirk O. Stimulation of insulin release by alpha-D-glucose pentaacetate. Biochem. Biophys. Res. Commun. 1997; 231: 435-6.
35. DeFronzo RA. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-87.
36. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 1990; 322: 223-8.
37. Kahn BB. Lilly lecture 1995. Glucose transport: Pivotal step in insulin action. Diabetes 1996; 45: 1644-54.
38. Zierath JR. In vitro studies of human skeletal muscle: Hormonal and metabolic regulation of glucose transport. Acta Physiol. Scand. Suppl. 1995; 626: 1-96.
39. Zierath JR, He L, Guma A, Odegoard Wahlstrom E, Klip A, Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996; 39: 1180-9.
40. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 1996; 45: 28-36.
41. Tsao TS, Burcelin R, Charron MJ. Regulation of hexokinase II gene expression by glucose flux in skeletal muscle. J. Biol. Chem. 1996; 271: 14959-63.
42. Tsao TS, Li J, Chang KS et al. Metabolic adaptations in skeletal muscle overexpressing GLUT4: Effects on muscle and physical activity. FASEB J. 2001; 15: 958-69.
43. Tsao TS, Stenbit AE, Li J et al. Muscle-specific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism. J. Clin. Invest. 1997; 100: 671-7.
44. Joost HG, Bell GI, Best JD et al. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am. J. Physiol. Endocrinol. Metab. 2002; 282: E974-6.
45. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: Nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr. Biol. 2001; 18: 247-56.